Minority enrollment in melanoma clinical trials
-
Published:2023-11
Issue:5
Volume:89
Page:1052-1054
-
ISSN:0190-9622
-
Container-title:Journal of the American Academy of Dermatology
-
language:en
-
Short-container-title:Journal of the American Academy of Dermatology
Author:
Munoz Elena Paz,
Patel Sapna P.,
Leachman Sancy A.,
Yu Nathan Y.,
Yu Wesley Y.ORCID
Reference5 articles.
1. Annual report to the Nation on the Status of Cancer, Part 1: National Cancer Statistics;Islami;J Natl Cancer Inst,2021
2. The ongoing racial disparities in melanoma: an analysis of the surveillance, epidemiology, and end results database (1975-2016);Qian;J Am Acad Dermatol,2021
3. Why ethnic minority groups are under-represented in clinical trials: a review of the literature;Hussain-Gambles;Health Soc Care Community,2004
4. Minority enrollment in phase II and III clinical trials in urologic oncology;Owens-Walton;J Clin Oncol,2022
5. Participation in cancer clinical trials: race-, sex-, and age-based disparities;Murthy;JAMA,2004